IT1133025B - Nuovi eteri per uso farmaceutico e procedimento per la loro preparazione - Google Patents

Nuovi eteri per uso farmaceutico e procedimento per la loro preparazione

Info

Publication number
IT1133025B
IT1133025B IT49108/80A IT4910880A IT1133025B IT 1133025 B IT1133025 B IT 1133025B IT 49108/80 A IT49108/80 A IT 49108/80A IT 4910880 A IT4910880 A IT 4910880A IT 1133025 B IT1133025 B IT 1133025B
Authority
IT
Italy
Prior art keywords
procedure
preparation
pharmaceutical use
new ethers
ethers
Prior art date
Application number
IT49108/80A
Other languages
English (en)
Italian (it)
Other versions
IT8049108A0 (it
Inventor
Geoffrey Kneen
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IT8049108A0 publication Critical patent/IT8049108A0/it
Application granted granted Critical
Publication of IT1133025B publication Critical patent/IT1133025B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/30Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/74Unsaturated compounds containing —CHO groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT49108/80A 1979-06-29 1980-06-27 Nuovi eteri per uso farmaceutico e procedimento per la loro preparazione IT1133025B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7922781 1979-06-29

Publications (2)

Publication Number Publication Date
IT8049108A0 IT8049108A0 (it) 1980-06-27
IT1133025B true IT1133025B (it) 1986-07-09

Family

ID=10506199

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49108/80A IT1133025B (it) 1979-06-29 1980-06-27 Nuovi eteri per uso farmaceutico e procedimento per la loro preparazione

Country Status (18)

Country Link
US (1) US4410537A (OSRAM)
EP (1) EP0022229B1 (OSRAM)
JP (1) JPS5649335A (OSRAM)
KR (2) KR850000073B1 (OSRAM)
AU (1) AU545274B2 (OSRAM)
DE (1) DE3061269D1 (OSRAM)
DK (1) DK159770C (OSRAM)
FI (1) FI71929C (OSRAM)
GB (1) GB2053218B (OSRAM)
GR (1) GR68748B (OSRAM)
HU (1) HU190774B (OSRAM)
IL (1) IL60422A (OSRAM)
IT (1) IT1133025B (OSRAM)
MW (1) MW2380A1 (OSRAM)
OA (1) OA06699A (OSRAM)
ZA (1) ZA803880B (OSRAM)
ZM (1) ZM5780A1 (OSRAM)
ZW (1) ZW14480A1 (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1193786B (it) * 1980-12-18 1988-08-24 Wellcome Found Composti eterei dotati di attivita' mitigatrice delle emoglobinopatie intermedi e procedimento per la loro preparazione
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
AU6019898A (en) 1997-01-09 1998-08-03 Cohesion Technologies, Inc. Devices for tissue repair and methods for preparation and use thereof
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
EP1226104B1 (en) * 1999-11-05 2009-04-08 Emisphere Technologies, Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
RU2300516C2 (ru) * 1999-11-05 2007-06-10 Эмисфере Текнолоджиз, Инк. Соединения феноксикарбоновой кислоты и композиции для доставки активных веществ
AU2001245823A1 (en) * 2000-03-17 2001-10-03 Corixa Corporation Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
EP2661264B1 (en) 2011-01-07 2018-12-05 Allergan, Inc. Melanin modification compositions and methods of use
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
SI2797416T1 (sl) 2011-12-28 2017-12-29 Global Blood Therapeutics, Inc. Substituirane spojine benzaldehida in metode njihove uporabe pri povečanju oksigenacije tkiva
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
MX379228B (es) * 2013-03-15 2025-03-10 Global Blood Therapeutics Inc Compuestos y usos de estos para la modulación de la hemoglobina.
BR112015021986A2 (pt) 2013-03-15 2017-07-18 Global Blood Therapeutics Inc compostos e seus usos para a modulação de hemoglobina
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
PE20151900A1 (es) 2013-03-15 2016-01-20 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina
EP3816155A1 (en) * 2013-08-23 2021-05-05 Virginia Commonwealth University Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
DK3102208T4 (da) 2014-02-07 2024-08-26 Global Blood Therapeutics Inc Krystallinsk polymorph af den frie base af 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyd
SG10202008673WA (en) 2015-03-06 2020-10-29 Beyondspring Pharmaceuticals Inc Method of treating cancer associated with a ras mutation
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
SG11201804647TA (en) 2015-12-04 2018-06-28 Global Blood Therapeutics Inc Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
NZ744854A (en) * 2016-02-08 2020-01-31 Beyondspring Pharmaceuticals Inc Compositions containing tucaresol or its analogs
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
WO2019182938A1 (en) * 2018-03-22 2019-09-26 Virginia Commonwealth University Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease
WO2020072377A1 (en) 2018-10-01 2020-04-09 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease
LT3880654T (lt) 2018-11-19 2022-02-25 Global Blood Therapeutics, Inc. 2-formil-3-hidroksifeniloksimetilo junginiai, galintys moduliuoti hemoglobiną
JP2024513505A (ja) 2021-04-09 2024-03-25 ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド 腫瘍を治療するための組成物及び方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL105100C (OSRAM) * 1958-04-30
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
CH550776A (de) 1971-03-05 1974-06-28 Ciba Geigy Ag Herstellung neuer bis-stilbenverbindungen.
DE2209128C3 (de) 1971-03-05 1981-10-22 CIBA-GEIGY AG, 4002 Basel Bis-Stilbenverbindungen, Verfahren zu deren Herstellung und deren Verwendung als optische Aufheller
GB1511645A (en) 1974-05-31 1978-05-24 Univ Ife Sickle cell anaemia treatment
US4137309A (en) * 1976-10-14 1979-01-30 The Procter & Gamble Company Therapeutic treatment

Also Published As

Publication number Publication date
OA06699A (fr) 1982-05-31
MW2380A1 (en) 1982-03-10
FI71929C (fi) 1987-03-09
EP0022229B1 (en) 1982-12-08
KR850000072B1 (ko) 1985-02-18
DK279780A (da) 1980-12-30
DK159770B (da) 1990-12-03
GB2053218B (en) 1984-01-25
ZM5780A1 (en) 1983-11-21
GR68748B (OSRAM) 1982-02-16
KR840004668A (ko) 1984-10-22
EP0022229A1 (en) 1981-01-14
KR850000073B1 (ko) 1985-02-18
IL60422A0 (en) 1980-09-16
ZW14480A1 (en) 1982-03-17
DK159770C (da) 1991-04-22
IL60422A (en) 1984-06-29
HU190774B (en) 1986-11-28
AU5969780A (en) 1981-01-08
DE3061269D1 (en) 1983-01-13
KR830002693A (ko) 1983-05-30
ZA803880B (en) 1982-02-24
AU545274B2 (en) 1985-07-11
FI71929B (fi) 1986-11-28
IT8049108A0 (it) 1980-06-27
FI802052A7 (fi) 1980-12-30
JPH0154339B2 (OSRAM) 1989-11-17
GB2053218A (en) 1981-02-04
JPS5649335A (en) 1981-05-02
US4410537A (en) 1983-10-18

Similar Documents

Publication Publication Date Title
IT1133025B (it) Nuovi eteri per uso farmaceutico e procedimento per la loro preparazione
IT1106143B (it) Peptidi e loro derivati per uso farmaceutico e procedimento per la preparazione delle formulazioni che li contengono
AR225314A1 (es) Procedimiento para la preparacion de nuevos derivados de indolizina
IT1143047B (it) Composti diazepinici per uso farmaceutico e loro procedimento di preparazione
IT1164076B (it) Composti farmaceutici ad azione antiulcera e procedimento per la loro preparazione
IT1188970B (it) Derivati della moranolina e procedimento per la loro preparazione
IT1129933B (it) Derivati tioetilammidici loro composizioni farmaceutiche e procedimento per la loro preparazione
IT8148166A0 (it) Ne e loro uso terapeutico esteri di mercaptoacil-carnitine procedimento per la loro preparazio
IT1147741B (it) Derivati di idrossiammino eburnano e procedimento per la loro preparazione
IT1132403B (it) Derivati di alovincamone e procedimento per la loro preparazione
AR229875A1 (es) Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos
IT1171361B (it) Amminociclopentanon-ammidi e procedimento per la loro preparazione e formulazione farmaceutica
IT1201523B (it) Eterociclilfenilfomramidine,processi per la loro preparazione e loro uso farmaceutico
IT1132404B (it) Derivati di 10-alo-e-omoeburnano e procedimento per la loro preparazione
IT1170862B (it) Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT7922035A0 (it) Alcossialchilidenidrazinopiridazine e procedimento per la loro preparazione.
IT1169459B (it) 1-piridilossi-3-indolilalchilammino-2-propanoli sostituiti,procedimento di preparazione e loro uso
IT8048512A0 (it) Composizioni antibatteriche a basedi cloresidina per uso dermatologico e procedimento per la loro preparazione
IT1130074B (it) Composti policiclici e procedimento per la loro preparazione
IT1212412B (it) Derivati della benzo-as-triazina e procedimento per la loro preparazione.
IT1193723B (it) Derivati di 1 fenil 4 morfolino 1 buten 3 olo procedimento per la loro preparazione e loro uso farmaceutico
IT1143906B (it) Tiocarnitine procedimento per la loro preparazione e loro uso terapeutico
IT1169903B (it) Derivati epossicarbaciclinici, loro preparazione e loro uso
IT8067851A0 (it) Derivati di cefalosporina sommini strabili per via orale e procedimento per la loro preparazione
IT8024015A0 (it) Derivati del15-idrossi-e-omoeburnano alogenati e procedimento per la loro preparazione.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940629